2002PubMedRequires access

[Nifedipine first choice in management of threatening preterm labor].

Dimitri N.M. Papatsonis, Catharina C.M. Timmerman, S.G. Oei, Herman P. van Geijn

Open publisher page 1 citations

Abstract

Preterm birth is the most important cause of perinatal mortality in Europe and North America. Tocolytic agents named beta 2-sympathicomimetics postpone delivery for 24-48 hours, but do not reduce perinatal mortality or morbidity. Calcium antagonists, in particular nifedipine, are more effective tocolytic agents than beta 2-sympathicomimetics in terms of delaying delivery. Meta-analyses have found that calcium antagonists statistically significantly reduced perinatal morbidity and that the number of maternal side effects was statistically significantly lower compared with beta 2-sympathicomimetics. Nifedipine also has the benefit of oral administration, in contrast with beta 2-sympathicomimetics which are administered intravenously. Nifedipine is therefore the first choice in the management of threatening preterm labour.

About this research paper

What this paper is about

Preterm birth is the most important cause of perinatal mortality in Europe and North America. Tocolytic agents named beta 2-sympathicomimetics postpone delivery for 24-48 hours, but do not reduce perinatal mortality or morbidity. Calcium antagonists, in particular nifedipine, are more effective tocolytic agents than beta 2-sympathicomimetics in terms of delaying delivery. Meta-analyses have found that calcium antagonists statistically significantly reduced perinatal morbidity and that the number of maternal side effects was statistically significantly lower compared with beta 2-sympathicomimetics. Nifedipine also has the benefit of oral administration, in contrast with beta 2-sympathicomimetics which are administered intravenously. Nifedipine is therefore the first choice in the management of threatening preterm labour.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Preterm birth is the most important cause of perinatal mortality in Europe and North America. Tocolytic agents named beta 2-sympathicomimetics postpone delivery for 24-48 hours, but do not reduce perinatal mortality or morbidity. Calcium antagonists, in particular nifedipine, are more effective tocolytic agents than beta 2-sympathicomimetics in terms of delaying delivery. Meta-analyses have found that calcium antagonists statistically significantly reduced perinatal morbidity and that the number of maternal side effects was statistically significantly lower compared with beta 2-sympathicomimetics. Nifedipine also has the benefit of oral administration, in contrast with beta 2-sympathicomimetics which are administered intravenously. Nifedipine is therefore the first choice in the management of threatening preterm labour.

Key concepts: Nifedipine, Medicine, Tocolytic agent, Tocolytic, Preterm labour, Preterm labor, Preterm delivery, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
[Nifedipine first choice in management of threatening preterm labor]. — Research Paper | ScholarLens